Immunization, Hib3 in Congo, Democratic Republic of the
Congo, Democratic Republic of the: Immunization, Hib3 was 65.0% in 2024. ▼ Falling
Immunization, Hib3 in Congo, Democratic Republic of the, 2009–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
Congo, Democratic Republic of the recorded 65.0% for immunization, hib3 in 2024.
The figure is up 8.3% on the previous year and down 11.0% over ten years.
Over the whole period, immunization, hib3 in Congo, Democratic Republic of the peaked at 73.0% in 2014 and was at its lowest, 60.0%, in 2010.
Congo, Democratic Republic of the ranks 176th of 191 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 16 years of available data.
Immunization, Hib3 in Congo, Democratic Republic of the, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2009 | 71.0% | — |
| 2010 | 60.0% | -15.5% |
| 2011 | 70.0% | +16.7% |
| 2012 | 71.0% | +1.4% |
| 2013 | 71.0% | +0.0% |
| 2014 | 73.0% | +2.8% |
| 2015 | 70.0% | -4.1% |
| 2016 | 70.0% | +0.0% |
| 2017 | 71.0% | +1.4% |
| 2018 | 71.0% | +0.0% |
| 2019 | 73.0% | +2.8% |
| 2020 | 70.0% | -4.1% |
| 2021 | 65.0% | -7.1% |
| 2022 | 65.0% | +0.0% |
| 2023 | 60.0% | -7.7% |
| 2024 | 65.0% | +8.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 71.0% | 71.0% | 71.0% | 1 |
| 2010s | 70.0% | 60.0% | 73.0% | 10 |
| 2020s | 65.0% | 60.0% | 70.0% | 5 |
Countries ranked near Congo, Democratic Republic of the
More health data for Congo, Democratic Republic of the
- Un projection of annual infant deaths, annual growth rate -1.56 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.03 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 821.4 deaths per 1,000 people (2090)
- Number of infants who die before age 1 133,650 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.076 units per person (2025)
- Population ages 05-09, male, annual growth rate 3.29 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0763 units per person (2025)
- Population ages 10-14, female, annual growth rate 3.53 % change on previous year (2025)
Frequently asked questions
- What is immunization, hib3 in Congo, Democratic Republic of the?
- Immunization, hib3 in Congo, Democratic Republic of the was 65.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Congo, Democratic Republic of the?
- The highest recorded value was 73.0% in 2014.
- What is the lowest immunization, hib3 recorded in Congo, Democratic Republic of the?
- The lowest recorded value was 60.0% in 2010.
- How does Congo, Democratic Republic of the rank for immunization, hib3?
- Congo, Democratic Republic of the ranks 176th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Congo, Democratic Republic of the?
- Over the last ten years it is down 11.0%. The long-run trend across the full record is falling.
- Where does this Congo, Democratic Republic of the data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 16 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.